Ciclosporin in the prevention of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Trial Profile

Ciclosporin in the prevention of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Myocardial infarction; Reperfusion injury
  • Focus Registrational; Therapeutic Use
  • Acronyms CIRCUS
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 13 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 31 Aug 2015 According to NeuroVive Pharmaceuticals media release, results will be presented at the European cardiology meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top